Evidence map›Paper›PMID 23165466›Full record

ArticleAntimicrobial agents and chemotherapy2013

In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.

Frédéric Lamoth, Praveen R Juvvadi, Christopher Gehrke, William J Steinbach

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Potential Antifungal Targets forInternational journal of molecular sciences · 2022
    Review
  13. Review
  14. Therapeutic Approaches for CombatingCurrent drug targets · 2022
    Review
  15. Azole Resistance in Clinical and EnvironmentalJournal of fungi (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Combination Therapy to Treat Fungal Biofilm-Based Infections.International journal of molecular sciences · 2020
    Review
  19. Review
  20. Novel Antifungal Agents and Their Activity againstJournal of fungi (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Frédéric LamothDivision of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
Praveen R Juvvadi
Christopher Gehrke
William J Steinbach
Duke Medical Center · USDuke University Hospital · US

Funding

Calcineurin Inhibition to Halt Aspergillus fumigatus Hyphae and VirulenceR56AI077648 · NIAID · DUKE UNIVERSITY · PI STEINBACH, WILLIAM J · 2010 to 2010
$393k
NIAID NIH HHS 1R56AI077648-01A2NIAID NIH HHS R56 AI077648
6 · The paper itself

Abstract

Due to the limited number of antifungals and the emergence of resistance, new therapies against invasive aspergillosis are needed. We show that calcineurin inhibitors are active in vitro against both azole- and echinocandin-resistant Aspergillus fumigatus strains. The heat shock protein 90 (Hsp90) inhibitor geldanamycin had modest activity when used alone, but its combination with caspofungin or tacrolimus (FK506) resulted in fungicidal activity against azole-resistant strains. Targeting the Hsp90-calcineurin axis is a promising alternative strategy against azole-resistant A. fumigatus strains.

Indexed as

Calcineurin InhibitorsAntifungal AgentsAspergillosisAspergillus fumigatusAzolesBenzoquinonesCaspofunginDrug Resistance, Multiple, FungalDrug Therapy, CombinationEchinocandinsHSP90 Heat-Shock ProteinsLactams, MacrocyclicLipopeptidesMicrobial Sensitivity TestsTacrolimusAntifungal AgentsAzolesBenzoquinonesCalcineurin InhibitorsCaspofunginEchinocandinsgeldanamycinHSP90 Heat-Shock ProteinsLactams, MacrocyclicLipopeptidesTacrolimus

Identifiers

PMID23165466
PMCPMC3553695
OpenAlexW2120004156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.